Breaking: J.P. Morgan Reiterates $106.0000 Price Target On CVS Health (NYSE:CVS) Shares, Reiterates Their Original Buy Rating

CVS Health Corporation (NYSE:CVS) Logo

Investors sentiment increased to 1.07 in 2018 Q2. Its up 0.17, from 0.9 in 2018Q1. It increased, as 65 investors sold CVS Health Corporation shares while 477 reduced holdings. 119 funds opened positions while 459 raised stakes. 816.99 million shares or 0.49% less from 821.03 million shares in 2018Q1 were reported.

Amica Pension Fund Board Of Trustees has 40,787 shares for 0.36% of their portfolio. Valicenti Advisory Svcs Inc holds 64,481 shares or 1.91% of its portfolio. Puzo Michael J reported 1.85% in CVS Health Corporation (NYSE:CVS). Heartland Advisors Incorporated holds 0.59% or 138,713 shares. Pitcairn holds 8,917 shares. Toth Fin Advisory stated it has 87,947 shares or 1.33% of all its holdings. 41,382 were reported by Willingdon Wealth Mngmt. Diligent Investors Lc owns 23,294 shares or 0.91% of their US portfolio. Parkside Retail Bank holds 0.02% or 737 shares. White Pine Capital Lc accumulated 0.28% or 11,886 shares. Veritas Investment Mngmt (Uk) Limited owns 234,023 shares for 4.89% of their portfolio. Bright Rock Ltd Liability Corporation accumulated 113,000 shares. Canal Ins Company has invested 2.13% of its portfolio in CVS Health Corporation (NYSE:CVS). Columbia Asset Mngmt holds 18,044 shares or 0.34% of its portfolio. Buckingham Asset Limited Co holds 5,468 shares.

Since August 27, 2018, it had 0 insider buys, and 5 sales for $4.91 million activity. On Monday, October 1 the insider Boratto Eva C sold $354,080. $642,300 worth of CVS Health Corporation (NYSE:CVS) shares were sold by Hourican Kevin. On Monday, October 1 the insider Bisaccia Lisa sold $1.72 million.

CVS Health (NYSE:CVS) Rating Reaffirmed

J.P. Morgan now has a $106.0000 target price per share on the $81.71B market cap company or 32.17 % upside potential. In a research report revealed on Wednesday, 28 November, CVS Health (NYSE:CVS) shares have had their Buy Rating restate by investment analysts at J.P. Morgan.

CVS Health Corporation (NYSE:CVS) Ratings Coverage

Among 7 analysts covering CVS Health (NYSE:CVS), 5 have Buy rating, 0 Sell and 2 Hold. Therefore 71% are positive. CVS Health has $10600 highest and $80 lowest target. $90’s average target is 12.22% above currents $80.2 stock price. CVS Health had 7 analyst reports since July 3, 2018 according to SRatingsIntel. The rating was maintained by Morgan Stanley on Tuesday, July 3 with “Overweight”. The rating was initiated by Goldman Sachs on Thursday, November 29 with “Hold”. J.P. Morgan maintained CVS Health Corporation (NYSE:CVS) on Wednesday, November 28 with “Buy” rating. The rating was initiated by Cantor Fitzgerald on Monday, November 26 with “Buy”. The firm has “Buy” rating by Citigroup given on Monday, July 9. As per Monday, September 17, the company rating was maintained by Bank of America.

The stock increased 0.25% or $0.2 during the last trading session, reaching $80.2. About 15.92M shares traded or 94.53% up from the average. CVS Health Corporation (NYSE:CVS) has declined 6.20% since December 2, 2017 and is downtrending. It has underperformed by 21.82% the S&P500.

CVS Health Corporation, together with its subsidiaries, provides integrated pharmacy health care services. The company has market cap of $81.71 billion. It operates through Pharmacy Services and Retail/LTC divisions. It has a 26.37 P/E ratio. The Pharmacy Services segment offers pharmacy benefit management solutions, such as plan design and administration, formulary management, Medicare Part D services, mail order, specialty pharmacy and infusion services, retail pharmacy network management services, prescription management systems, clinical services, disease management programs, and medical pharmacy management services.

More notable recent CVS Health Corporation (NYSE:CVS) news were published by: Benzinga.com which released: “Analysts Love CVS Health Shares Following Aetna Deal (NYSE:CVS)(NYSE:AET) – Benzinga” on November 27, 2018, also Seekingalpha.com with their article: “Cantor sees 23% upside in CVS Health in premarket analyst action – Seeking Alpha” published on November 27, 2018, Benzinga.com published: “CVS Corporation (NYSE:CVS) – CVS Q3 Earnings Preview – Benzinga” on November 05, 2018. More interesting news about CVS Health Corporation (NYSE:CVS) were released by: Fool.com and their article: “CVS Health’s Big Story in the 3rd Quarter: Ready for Aetna – Motley Fool” published on November 06, 2018 as well as Bizjournals.com‘s news article titled: “CVS set to close $69B Aetna merger after final state approvals – Boston Business Journal” with publication date: November 26, 2018.

CVS Health Corporation (NYSE:CVS) Institutional Positions Chart

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.